Wilson Sonsini Goodrich & Rosati advised Yuno on this transaction. Yuno announced that it completed a $25 million Series A funding round led by DST Global...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Microchip Technology Incorporated in the offering, and Simpson Thacher & Bartlett represented the underwriters. Microchip Technology Incorporated (Microchip) (Nasdaq: MCHP) priced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Lyft in the offering, and Goodwin Procter represented the initial purchasers. Lyft, Inc. (“Lyft”) (NASDAQ: LYFT) closed its offering of 0.625%...
You must be a Standard 1 Year member to access this content.
Paul Hastings secured an outright victory in the California Court of Appeal on behalf of William Morris Endeavor Entertainment, LLC (“WME”), when the panel affirmed the...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis is representing WeBull Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati is representing SK Growth Opportunities Corporation. Webull Corporation (“Webull” or the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised vTv Therapeutics on patent matters related to the transaction. vTv Therapeutics, a clinical-stage biopharmaceutical company, announced the closing of a private...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised AppLovin Corporation on the deal, and Fenwick & West advised the underwriters. AppLovin Corporation (NASDAQ: APP) (“AppLovin” or the “Company”),...
You must be a Standard 1 Year member to access this content.
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Avidity on patent matters related to the transaction. Avidity Biosciences, Inc. (Nasdaq: RNA) announced that it has agreed to sell 15,224,773...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Oishii on the transaction, and Pillsbury Winthrop Shaw Pittman advised McWin Capital Partners. Oishii, a vertical strawberry farming company, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics Inc. on the transaction. Denali Therapeutics (Nasdaq: DNLI) announced that it entered into a securities purchase agreement with...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Prime Medicine and Wilson Sonsini Goodrich & Rosati advised Prime Medicine on IP matters related to the transaction, while Davis Polk & Wardwell...
You must be a Standard 1 Year member to access this content.
